chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Slur of words; tightness R jaw; ear pain; This is a spontaneous report from a contactable Nurse. A 48-Year-old Non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Formulation: Solution for injection, Lot number & expiry date not reported) dose 1 via unspecified route of administration on 12Feb2021 (at age of 48years) as 1st dose single for COVID-19 Immunization. Patient medical history and concomitant medications are not reported. Patient also received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Formulation: Solution for injection, Lot number & expiry date not reported) dose 2 via unspecified route of administration on 03May2021 as 2nd dose single for Covid-19 immunization.Patient didnt receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19 was unknown On 12Feb2021, (On day of vaccination),Patient experienced Slur of words, tightness R jaw, Ear Pain. Patient received treatment for the adverse events by Depomedrol shot. Patient had to visit clinic for adverse events. The Clinical outcome of all events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect vaccine BNT162B2 or comirnarty in triggering the onset of slurred speech,tightness of jaw muscles,ear pain cannot be excluded.The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Committees and Investigators, as appropriate.
04/14/2021 Noticed around 1:00 p.m. that my left eyelid was sagging.  Concerned it may be a symptom of a stroke, I rushed to the emergency room at Hospital.   They admitted me and ran a variety of tests, one of which was an MRI which concluded that I had not had a stroke.  The neurologist stated that it appeared to be similar to a wrinkle.  Not sure what caused that sudden event.  Possibly a side affect of the COVID `19  shot.   Therefore the report.  I returned home the next day, 04/15/2021.
Pt vaccinated with DTP mother reported that following child first imm at age 2 mo chil slept 14 straight hrs.  Event reported when mother brought child in for 4 mo immunization
Dizzy, couldn?t do normal housework, breathless after little exertions, terrible headaches . After 10 Days went to Yavapai Regional Medical Center ER and was admitted with high blood pressure 225/97.
Mom states that "her daughter had a case of Chickenpox, I took her into the family doctor to check-He said it was Chickenpox, and that I should notify the one who gave her the vaccine."
small erythematous pruritic wheals on bilateral antecubital fossa and right forearm
This spontaneous report was received from a health care worker refers to 10 unspecified patients. Patients medical history and current condition was not reported. On an unknown date the patients were vaccinated with improperly stored doses or ROTATEQ (Lot number and expiry date not reported). No adverse effects reported. Product quality complaint was not reported. The outcome of the event was unknown. This is one of the two reports from the same reporter. Additional information has been requested.
sore arm; arm redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and ERYTHEMA (arm redness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and ERYTHEMA (arm redness). At the time of the report, PAIN IN EXTREMITY (sore arm) had resolved and ERYTHEMA (arm redness) had not resolved.            No concomitant medication was reported.  Treatment drug information was not given.   This case was linked to MOD-2021-062907 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Updated the outcome of the event erythema from unknown to not recovered.
Rashing at injection site; Welting at injection site; This is a spontaneous report from a contactable healthcare professional. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07May2021 at 15:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus, hypereosinophilic syndrome, endometriosis, adenomyosis, hypothyroidism, mast cell activation syndrome (MCAS), postural orthostatic tachycardia syndrome(POTS). The patient reported allergies to methylprednisolone sodium succinate (SOLUMEDROL) and levofloxacin(LEVAQUIN), diphenhydramine hydrochloride (IV BENADRYL), propofol (MANUFACTURER UNKNOWN) and walnuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included promethazine (MANUFACTURER UNKNOWN) and ondansetron (ZOFRAN); taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 04:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 10:00, the patient experienced rashing and welting at injection site. The events did not result in doctor or other healthcare professional office, clinic visit, and emergency room, department or urgent care. Therapeutic measures were taken as a result of events rashing and welting at injection site included treatment with antihistamine on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rashing and welting at injection site were not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
I'm not sure if this is an after effect of the Moderna shot. I developed a mild cough a day or so after receiving the shot. There didn't appear to be any other adverse effects. However, approximately 2 weeks after receiving the shot, I've begun running a low grade ever, a sore throat, fatigue, sneezing and running nose, swelling of eyes, etc. I have not sought medical attention.
pt recv vax 2FEB96 & pt became extremely cranky & devel a fever of 102;pt family believed pt to be teething & tx w/APAP;3FEB96 & 4FEB96 pt feb, restless, & did not sleep well;5FEB96 t101;pt not moving lt side of face;viral ear infect
pt recv vax 20JUN95 & 5SEP96 pt exp multiple papules on trunk, arms & face;
Pfizer-BioNTech COVID-19 Vaccine EUA Chills and low grade fever (highest it got was 99.7)- started at 11:00 p.m. on 11/12/21.  Not able to sleep in the night, headache started sometime in the night.  Fever and chills were gone by morning.  Headache resolved about 5:00 p.m. on 1/13/21.
The pt became pale and diaphoretic. BP 160/100; HR 128 and Resp 32. She was shaky, nauseated. Dextrostix-32. She was unable to keep blood sugar up X 12 hours. Treated with 50% Dextrose X 3 over the next 3 hours and 3L D5W. Returned to normal after 18 hours. She is not diabetic or hypoglycemic.
didn't go get the second one (>36 days between doses); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (didn't go get the second one (>36 days between doses)) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 40518(B)21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (didn't go get the second one (>36 days between doses)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (didn't go get the second one (>36 days between doses)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment drugs were reported.
2nd dose given on 4/14/23, resident sent out for chest pain on 4/16/23. Was reported to facility that on 4/18/23, resident was being taken to OR for open heart surgery.
FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the subject experienced fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103.9 F, 102.3 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. This report was non-serious.
Patient did not have any adverse events.  Patient is 16 years old and this vaccine is indicated for patients 18 years of age and older.
Patient received vaccination and after approximately 20 minutes reported dizziness and "tongue feeling weird".  Vital signs were obtained with BP 120/76, HR 120, RR 16, and SPO2 99%.  Patient was taken via wheelchair to the emergency department where diphenhydramine, famotidine, methylprednisolone, and lorazepam was administered.  Patient was monitored in the emergency department and then discharged home.
Pt fainted at about 3:50pm at the waiting area after blood drawn and vaccination, she felt dizzy then passed out for less than 1 min.  Code blue was called, pt was attended immediately by nursing staff and provider, she was awake by the time provider arrived.  Pt was transferred to Rm 9 for close observation, continuring monitor of vital signs.  Initial accessment by provider was normal, pt was observed for 30 mins with normal vital signs.  Pt was examined again by provider before discharge, normal exam.  Explained to mom that the fainting might be dued to blood drawn or vaccination.  Possible postvaccination reaction to HPV, case is reported for further investigation.   Pt should have f/u in 1 week.
Pt recvd 2 doses of Engerix-B vax & had tingling rt arm & leg down rt side, dusky color, tingling spread to lt side, weakness, lightheaded, difficulty breathing, confused, disoriented; seen by MD;
Patient became dizzy, began sweating & became pale in color. The symptoms lasted approximately 10-15 minutes. EMS checked patient: he remained at work afterwards.
This spontaneous case was reported by a consumer and describes the occurrence of MICTURITION DISORDER (About to pass out), PAIN IN EXTREMITY (Soreness in her arm), NAUSEA (Nauseous), FATIGUE (Feeling tired) and HEADACHE (headache) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her arm), NAUSEA (Nauseous), FATIGUE (Feeling tired) and HEADACHE (headache). On 02-Mar-2021, the patient experienced MICTURITION DISORDER (About to pass out). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. On 03-Mar-2021, NAUSEA (Nauseous) had resolved. At the time of the report, MICTURITION DISORDER (About to pass out), PAIN IN EXTREMITY (Soreness in her arm), FATIGUE (Feeling tired) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.
flu-like symptoms; heat at the injection site; redness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of flu-like symptoms in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID VACCINE) for prophylaxis.   The patient's past medical history included cellulitis. Concurrent medical conditions included thyroid disorder and shingles.   On 28th June 2022, the patient received the 1st dose of Shingrix (intramuscular) and the 4th dose of COVID VACCINE. On 28th June 2022, less than a day after receiving Shingrix, the patient experienced flu-like symptoms, injection site warmth and injection site redness. On an unknown date, the outcome of the flu-like symptoms was recovered/resolved and the outcome of the injection site warmth and injection site redness were not recovered/not resolved.   It was unknown if the reporter considered the flu-like symptoms, injection site warmth and injection site redness to be related to Shingrix.     Additional Information: GSK Receipt Date: 30-JUN-2022 Reporter's Comments: The reporter was the patient. The patient had redness and heat at the injection site. The redness and heat increased the next day of vaccination but had not worsened on the day of reporting. The first evening she had flu-like symptoms.  On an unknown date in June 2022, the outcome of the flu-like symptoms was recovered/resolved. Patient also had her fourth COVID vaccine (unknown manufacturer) on the same day in the same arm, below the Shingrix injection site.  On 28th June 2022, less than a day after receiving Covid vaccine, the patient experienced flu-like symptoms, injection site warmth and injection site redness. It was unknown if the reporter considered the flu-like symptoms to be related to Covid vaccine. The reporter did not suspect the area of redness and heat were due to the COVID vaccine.  She had nothing else to report.  The reporter consented to follow up.
This spontaneous report as received from a nurse refers to a 12 month old patient (gender unspecified). On 18-MAR-2014, the patient was vaccinated with PROQUAD injection, dose 0.5 ml, subcutaneous that was stored (outside prescribing information) at 30 Fahrenheit (F) for 2.5 hours. Concomitant therapy was unspecified. No adverse effect was reported. No product quality complaint was involved. The outcome of received PROQUAD that was stored (outside prescribing information) at 30 F for 2.5 hours was unknown. No further information was provided. Additional information has been requested.
got a shingles shot / ended up getting the shingles!/Suspected Vaccination failure; Shingles! / twice; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient's sister. The age at vaccination was not reported. The patient got a Shingles shot and she ended up getting the shingles. Not once, but twice. The reporter reported that the patient's doctor had recommended one. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
This spontaneous report was received from a registered nurse, concerning a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 27-AUG-2018, the patient received one dose of VAQTA 25U/0.5ml, per intramuscular route, lot # R013859 and expiration date on 14-JUN-2019, for prophylaxis. The vaccine was administered following a possible temperature excursion. The temperatures and time frames of the possible temperature excursion were unknown and were not recorded by a data logger. The vaccine had not had any previous temperature excursions. There was no adverse effect reported. No product quality complaint was involved.
Since getting the vaccine, I have been getting a rash that has white bumps that pops up on my skin. They are itchy and will disappear after 30 minutes then pop up somewhere else. They are worse in the evening. They appear on the palms of my hand, shoulders, arms, back of legs, and ankles. They just come and go. It is more likely to appear on areas of my body where stuff rubs up against my skin. It doesn't stay on one spot for long. It has been over 3 weeks that I am experiencing this. I am able to stop the rash by taking Zyrtec. 48 hours is the longest I have gone without the rash coming back.
Patient presented extreme welts, and rashes radially along arms and legs, and spread within 2 hours of visible identification. Look like hives or shingles
Information has been received from a physician concerning a male patient who developed varicella and secondary transmission from his son, who had been vaccinated with VARIVAX (Oka/Merck) and developed shingles (WAES# 0805USA00862). The physician noted "the child's father has now developed chickenpox and that samples from him are also being tested".
Arm soreness; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Spontaneous abortion, Alcohol use (A year ago), Marijuana use (Not in the last 6 months) and Pregnancy (live full-time birth).    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm soreness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   This case was linked to MOD-2021-014833 (Patient Link).
Systemic: metallic taste in mouth-Medium, Additional Details: Patient developed severe metallic taste in mouth right after receiving vaccine and has not recovered
Patient developed pleuritic chest pain 5 hours after the injection, which lasted less than 1 day and resolved.
My eyes felt like there was a film over them, was hard to drive pulled over and washed eyes out with plenty of cold water. Did not help.  Reached where was going to felt edgy and started to get sick to my stomach. Went to girl friends house 5 miles away drove there no problem's driving.  When got to her house about 7PM felt nauseated.  Went to bed around 10PM was having trouble breathing short of breath used albuterol inhaler also have concentrator that use for borderline sleep apnea, set at 2.  Woke up about 1.5 hours later to go to the bathroom and felt like my head was going to explode felt really sick like I had the flu.  Stayed up til 1:am on the 10/12/2014 went back to bed and in the morning got up about 9;am and felt like I was hung over from a drinking binge. After a couple of hours like 4Pm in the afternoon felt fine.  Except had a rash forming on the left and right side of my nose, not on the nose but to each side. Just a slight redness and it is still with me today. Went to Urgent Care yesterday 10/21/2014 and got a Rx from the doctor there.  My girl friend is a RN and if she had not been there with me would have called emergency services as would not been able to handle the situation by myself.
Patient stated she had some numbness start in vaccination arm and travel to other arm and legs.  Also, some numbness in chest.  Symptoms started 9/24/16 but reported 9/25/16.  Symptoms have been self resolving.
Immunization site left leg red and hot to touch, hard/tight, swollen. Treated with augmentin 600/5 Tsp BID for 7 days for possible early cellulitis.
Two hours after vaccines administered infant with high pitched non stop crying for 24 hours.  Fever 103, swollen site, and diff breathing for 24 hours.  Treated at home with Tylenol every four hours.  Contacted the ER by phone per family and instructed to continue with Tyl and if breathing worsened to go to ER.  Mom up all night with infant and evaluated per Dr on 08/18/07.  Symptoms subsided after 24 hours and Dr. instructed family to not give Pertussis in the vaccine.  3 maternal Uncles had mod -severe reactions to Pertussis.  One Uncle passed away at 4 mos of age from the pertussis vaccine.  Other two Uncles had mod reactions.  One with seizures and other with same symptoms as patient.
injection site was raised; iinjection site was red; injection site was warm; headache; has been a little tired; Had a little soreness went away in 1 day; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Had a little soreness went away in 1 day), HEADACHE (headache), FATIGUE (has been a little tired), INJECTION SITE SWELLING (injection site was raised) and INJECTION SITE ERYTHEMA (iinjection site was red) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included PROBIOTICS NOS for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced INJECTION SITE PAIN (Had a little soreness went away in 1 day). On 12-Jan-2021, the patient experienced HEADACHE (headache) and FATIGUE (has been a little tired). On 18-Jan-2021, the patient experienced INJECTION SITE SWELLING (injection site was raised), INJECTION SITE ERYTHEMA (iinjection site was red) and INJECTION SITE WARMTH (injection site was warm). The patient was treated with PARACETAMOL (TYLENOL) for Inflammation, at an unspecified dose and frequency. On 12-Jan-2021, INJECTION SITE PAIN (Had a little soreness went away in 1 day) had resolved. At the time of the report, HEADACHE (headache), FATIGUE (has been a little tired), INJECTION SITE SWELLING (injection site was raised), INJECTION SITE ERYTHEMA (iinjection site was red) and INJECTION SITE WARMTH (injection site was warm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.